Literature DB >> 23538408

New applications of nanotechnology for neuroimaging.

G Suffredini1, J E East2, L M Levy3.   

Abstract

SUMMARY: Advances in nanotechnology have the potential to dramatically enhance the detection of neurologic diseases with targeted contrast agents and to facilitate the delivery of focused therapies to the central nervous system. We present the physicochemical rationale for their use, applications in animal models, and ongoing clinical trials using these approaches. We highlight advances in the use of nanoparticles applied to brain tumor imaging, tumor angiogenesis, neurodegeneration, grafted stem cells, and neuroprogenitor cells.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538408      PMCID: PMC7966599          DOI: 10.3174/ajnr.A3543

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  69 in total

Review 1.  Control of brain capillary blood flow.

Authors:  Yoshiaki Itoh; Norihiro Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-01       Impact factor: 6.200

Review 2.  Nitric oxide neurons and neurotransmission.

Authors:  Steven R Vincent
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

Review 3.  Nitric oxide signaling in the central nervous system.

Authors:  J Garthwaite; C L Boulton
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

Review 4.  Function and regulation of the beta 3 integrins in hemostasis and vascular biology.

Authors:  S J Shattil
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249

5.  FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.

Authors:  Min Lu; Martin H Cohen; Dwaine Rieves; Richard Pazdur
Journal:  Am J Hematol       Date:  2010-05       Impact factor: 10.047

6.  Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells.

Authors:  Alyona Sukhanova; Jérôme Devy; Lydie Venteo; Hervé Kaplan; Mikhail Artemyev; Vladimir Oleinikov; Dmitry Klinov; Michel Pluot; Jacques H M Cohen; Igor Nabiev
Journal:  Anal Biochem       Date:  2004-01-01       Impact factor: 3.365

7.  Specific visualization of glioma cells in living low-grade tumor tissue.

Authors:  Sven R Kantelhardt; Wouter Caarls; Anthony H B de Vries; Guy M Hagen; Thomas M Jovin; Walter Schulz-Schaeffer; Veit Rohde; Alf Giese; Donna J Arndt-Jovin
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

8.  Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma.

Authors:  Ruimin Huang; Jelena Vider; Joy L Kovar; D Michael Olive; Ingo K Mellinghoff; Philipp Mayer-Kuckuk; Moritz F Kircher; Ronald G Blasberg
Journal:  Clin Cancer Res       Date:  2012-08-22       Impact factor: 12.531

9.  Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology.

Authors:  Bernard M Tijink; Toon Laeremans; Marianne Budde; Marijke Stigter-van Walsum; Torsten Dreier; Hans J de Haard; C René Leemans; Guus A M S van Dongen
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

10.  In vivo detection of amyloid-β deposits using heavy chain antibody fragments in a transgenic mouse model for Alzheimer's disease.

Authors:  Rob J A Nabuurs; Kim S Rutgers; Mick M Welling; Athanasios Metaxas; Maaike E de Backer; Maarten Rotman; Brian J Bacskai; Mark A van Buchem; Silvère M van der Maarel; Louise van der Weerd
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

View more
  1 in total

1.  Evolution and Clinical Translation of Drug Delivery Nanomaterials.

Authors:  Shabir Hassan; Gyan Prakash; Aycabal Ozturk; Saghi Saghazadeh; Mohammad Farhan Sohail; Jungmok Seo; Mehmet Dockmeci; Yu Shrike Zhang; Ali Khademhosseini
Journal:  Nano Today       Date:  2017-08-02       Impact factor: 20.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.